Compare IBRX & AROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IBRX | AROC |
|---|---|---|
| Founded | 2014 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 6.5B |
| IPO Year | 2015 | 2007 |
| Metric | IBRX | AROC |
|---|---|---|
| Price | $7.27 | $32.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | $12.57 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 13.3M | 1.7M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.32% |
| EPS Growth | 38.71 | ★ 74.29 |
| EPS | N/A | ★ 0.41 |
| Revenue | $113,288,000.00 | ★ $1,489,818,000.00 |
| Revenue This Year | $88.59 | $7.06 |
| Revenue Next Year | $131.15 | $5.27 |
| P/E Ratio | ★ N/A | $81.90 |
| Revenue Growth | ★ 668.31 | 28.70 |
| 52 Week Low | $1.95 | $21.17 |
| 52 Week High | $12.43 | $40.12 |
| Indicator | IBRX | AROC |
|---|---|---|
| Relative Strength Index (RSI) | 43.96 | 29.93 |
| Support Level | $6.64 | $23.47 |
| Resistance Level | $8.54 | $37.33 |
| Average True Range (ATR) | 0.54 | 1.20 |
| MACD | -0.07 | -0.58 |
| Stochastic Oscillator | 9.16 | 3.43 |
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
Archrock Inc is an energy infrastructure company focused on midstream natural gas compression. It is a provider of natural gas compression services, based on total compression fleet horsepower, to customers across the United States and a supplier of aftermarket services to customers that own compression equipment. The company operates through two segments: contract operations and aftermarket services. The contract operations segment includes designing, sourcing, owning, installing, operating, servicing, repairing, and maintaining its owned fleet of natural gas compression equipment, and generates the maximum revenue. The aftermarket services segment provides operations, maintenance, overhaul, and reconfiguration services, and sales of parts and components.